138 related articles for article (PubMed ID: 10572309)
1. Comparison of an antiviral activity of recombinant consensus interferon with recombinant interferon-alpha-2b.
Koyama AH; Arakawa T; Adachi A
Microbes Infect; 1999 Nov; 1(13):1073-7. PubMed ID: 10572309
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the antiviral activities of natural IFN-alpha preparations and their subtype compositions.
Yanai Y; Sanou O; Kayano T; Ariyasu H; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M
J Interferon Cytokine Res; 2001 Oct; 21(10):835-41. PubMed ID: 11710996
[TBL] [Abstract][Full Text] [Related]
3. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
[TBL] [Abstract][Full Text] [Related]
4. Loss of interferon alpha and interferon tau-induced antiviral protection in interferon regulatory factor-2 DNA-binding domain dominant negative mutants.
Rubinstein YR; Pontzer CH
Antiviral Res; 2000 Jun; 46(3):207-13. PubMed ID: 10867158
[TBL] [Abstract][Full Text] [Related]
5. Antiviral and protein-inducing activities of recombinant human leukocyte interferons and their hybrids.
Sen GC; Herz R; Davatelis V; Pestka S
J Virol; 1984 May; 50(2):445-50. PubMed ID: 6200607
[TBL] [Abstract][Full Text] [Related]
6. [Anti-SARS virus activities of different recombinant human interferons in cell culture system].
Duan ZJ; Zhang LL; Xie ZP; Yu ZA; Zhang LP; Zhang B; Liu YQ; Wang JW; Li WP; Zhang CH; Ma XJ; Shu YL; Duan SM; Li DX; Hou YD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):205-8. PubMed ID: 15340558
[TBL] [Abstract][Full Text] [Related]
7. Effect of combined alpha IFN and prostaglandin A1 treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells.
Pica F; Rossi A; Santirocco N; Palamara A; Garaci E; Santoro MG
Antiviral Res; 1996 Mar; 29(2-3):187-98. PubMed ID: 8739598
[TBL] [Abstract][Full Text] [Related]
8. [Properties of human alpha-interferon F and hybrid interferon F/D obtained from recombinant bacteria compared to the properties of an interferon preparation from human leukocytes].
Ovchinnikov IuA; Sverdlov ED; Tsarev SA; Monastyrskaia GS; Khodkova EM
Dokl Akad Nauk SSSR; 1983; 268(4):996-1000. PubMed ID: 6187523
[No Abstract] [Full Text] [Related]
9. Biological activities of synthetic peptides of the sequence of human interferon-alpha.
Eichmann E; Majarov VA; Kozhich AT; Noll F; Zav'yalov VP
Immunol Lett; 1990 Jul; 24(4):233-6. PubMed ID: 2167875
[TBL] [Abstract][Full Text] [Related]
10. [Sensitivity of different cell lines to interferons: the relative antiviral activity as a function of the interferon subtype].
Tonew M; Glück B; Ohme E; Wondraczek RH
J Basic Microbiol; 1989; 29(8):537-45. PubMed ID: 2559962
[TBL] [Abstract][Full Text] [Related]
11. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1.
Siebeck N; Hurley DJ; Garcia M; Greene CE; Köstlin RG; Moore PA; Dietrich UM
Am J Vet Res; 2006 Aug; 67(8):1406-11. PubMed ID: 16881854
[TBL] [Abstract][Full Text] [Related]
12. Effect of indomethacin, aspirin, and acetaminophen on in vitro antiviral and antiproliferative activities of recombinant human interferon-alpha 2a.
Takaoki M; Yamashita Y; Koike K; Matsuda S
J Interferon Res; 1988 Dec; 8(6):727-33. PubMed ID: 3230331
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic activities of human interferons are mediated by multiple response pathways.
Forti RL; Mitchell WM; Hubbard WC; Workman RJ; Forbes JT
Proc Natl Acad Sci U S A; 1984 Jan; 81(1):170-4. PubMed ID: 6320163
[TBL] [Abstract][Full Text] [Related]
14. [Methodological approaches to creating a liposomal form of human recombinant alpha 2-interferon].
Zolin VV; Luk'ianov AN; Nesterov AE; Kolokol'tsov AA; Torchilin VP; Popov VF; Vardanian NV; Antonov NA
Vestn Ross Akad Med Nauk; 1993; (2):29-31. PubMed ID: 7688615
[TBL] [Abstract][Full Text] [Related]
15. Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cells.
Li MC; Wang HY; Wang HY; Li T; He SH
Acta Pharmacol Sin; 2006 Apr; 27(4):453-9. PubMed ID: 16539846
[TBL] [Abstract][Full Text] [Related]
16. Potentiating effect of murine interferon-gamma-containing lymphokine preparations on the antiviral and antiproliferative effects of murine interferon-alpha/beta: identification of the potentiation factor as murine interferon-gamma itself.
Fleischmann WR; Fleischmann CM
Antiviral Res; 1984 Aug; 4(4):221-8. PubMed ID: 6091541
[TBL] [Abstract][Full Text] [Related]
17. Pegylation of IFN-alpha and antiviral activity.
Boulestin A; Kamar N; Sandres-Sauné K; Alric L; Vinel JP; Rostaing L; Izopet J
J Interferon Cytokine Res; 2006 Dec; 26(12):849-53. PubMed ID: 17238827
[TBL] [Abstract][Full Text] [Related]
18. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].
Hu CJ; Ozes ON; Klein SB; Blatt LM; Taylor MW
J Interferon Cytokine Res; 1995 Mar; 15(3):231-4. PubMed ID: 7584668
[TBL] [Abstract][Full Text] [Related]
20. Antitumor, antiviral and natural killer-inducing activities of human recombinant interferon-alpha in the guinea pig.
Kataoka T; Ishitsuka H; Tokunaga T
Jpn J Med Sci Biol; 1986 Apr; 39(2):97-103. PubMed ID: 3022044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
